In-Vitro Diagnostics for cardiology and neurology Market | Growth, Trends and Forecasts (2018-2023)
In-vitro Diagnostics for Cardiology and Neurology Market - Segmented by Type of Technology, Product, Application, and End-user - Growth, Trends, and Forecast (2019 - 2024)


APR 2018

In-vitro Diagnostics for Cardiology and Neurology Market - Segmented by Type of Technology, Product, Application, and End-user - Growth, Trends, and Forecast (2019 - 2024)

Purchase Report

The In-vitro diagnostics for cardiology and neurology market is expected to register a CAGR of 6.03%, during the forecast period, 2018 to 2023.  Due to increasing incidences of heart and neurological disorders, rapid adoption of point-of-care testing, along with increasing preference for personalized medicine, the in-vitro diagnostics market for cardiology and neurology in the North American region is expected to lead the global market during the forecast period.

Increasing Incidences of Chronic Diseases

According to Centers for Disease Control and Prevention, chronic diseases were the leading cause of death and disability in the United States. It also states that, in 2012, there were more than 117 million people or nearly half of all adults who had one or more chronic health condition. As of 2015, chronic diseases were responsible for 7 out of 10 deaths among Americans each year, and has also accounted for approximately 86% of the nation’s healthcare costs. This trend of prevalence of chronic diseases is likely to continue in the near future. Considering most of the chronic diseases are diagnosed by In-vitro tests, the increasing trend of chronic diseases is expected to drive the in-vitro diagnostics for cardiology and neurology market during forecast period.

In addition, increasing government healthcare expenditure, along with rapid adoption of point-of-care testing, is also expected to boost the global market.

Stringent Regulatory Framework

According to FDA (Food and Drug Administration), in-vitro diagnostics products fall under medical devices category. Since IVDs include products used to collect specimens, or to prepare or examine specimens (e.g., blood, serum, urine, spinal fluid, tissue samples) after they are removed from the human body, maximum precaution is needed to prevent contamination even within the device. The guidelines laid for these devices are to be strictly followed, denial of which may result in product recalls, and thus, many companies are reluctant to enter into this market, which is acting as a major restraint for the US in-vitro diagnostics market.

Additionally, lack of favorable reimbursement policies in the field of in-vitro diagnostics is also hindering the growth of the global market.

Immunoassay to Dominate the Market

The in-vitro diagnostics market is segmented by technology, product type, application type, and end-user. By technology type, immunoassay dominates the global in-vitro diagnostics for cardiology and neurology market, due to high accuracy of these tests, along with less time consumed. The advent of point-of-care testing, which mainly utilizes immunoassay technology is also a major factor responsible for driving the market for in-vitro diagnostics globally. Although, immunoassay dominates the market, the molecular diagnostics segment is expected to witness the highest CAGR in the overall market.


Key Developments in the Market

  • August 2017: ARCHITECT STAT High Sensitive Troponin-I test (currently available outside the U.S.) was developed by Abbott. This test can identify very low levels of cardiac troponin helping doctors to detect heart attack

Major Players: Abbott Laboratories, Inc., Johnson & Johnson, Becton, Dickson and Company, Danaher Corporation, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Alere, Inc., Roche Diagnostics Limited, and Siemens Healthcare, among others.

Reasons to Purchase this Report

  • Current and future in-vitro diagnostics for cardiology and neurology market outlook in the developed and emerging markets
  • Analyzing various perspectives of the market with the help of Porter’s five forces analysis
  • The segment that is expected to dominate the market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, market shares, and strategies employed by the major market players
  • 3-month analyst support, along with the Market Estimate sheet (in excel)

Customization of the Report

  • This report can be customized to meet your requirements. Please connect with our analyst, who will ensure you get a report that suits your needs

1. Table of Contents

2. Introduction

                2.1 Market Definition

3. Research Methodology

4. Executive Summary

5. Key Inferences

6. Market Overview

                6.1 Current Market Scenario

                6.2 Porter's Five Forces Analysis

                                6.2.1 Bargaining Power of Suppliers

                                6.2.2 Bargaining Power of Consumers

                                6.2.3 Threats of New Entrants

                                6.2.4 Threat of Substitute Product and Services

                                6.2.5 Competitive Rivalry Within the Industry

7. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

                7.1 Market Drivers

                                7.1.1 Increasing Incidences of Chronic Diseases

                                7.1.2 Increasing Government Healhtcare Expenditure and Consumer's Healthcare Spending

                                7.1.3 Rapid Adoption of Point of Care Testing

                7.2 Market Restraints

                                7.2.1 Unfavorable Reimbursement Policies

                                7.2.2 Stringent Regulatory Framework

                7.3 Opportunities

                7.4 Key challenges

8. Market segmentation

                8.1 By Technology

                                8.1.1 Clinical Chemistry

                                8.1.2 Immunoassay

                                8.1.3 Microbiology

                                8.1.4 Hematology

                                8.1.5 Molecular Diagnostics

                                8.1.6 Coagulation

                                8.1.7 Others

                8.2 By Product

                                8.2.1 Instruments

                                8.2.2 Consumables/Reagents

                8.3 By Application

                                8.3.1 Cardiology

                                8.3.2 Neurology

                8.4 By End-users

                                8.4.1 Academics

                                8.4.2 Hospitals & Laboratories

                                8.4.3 Pharmaceutical & Biotechnology

                                8.4.4 Others

                8.5 By Geography

                                8.5.1 North America

                                       United states



                                8.5.2 Europe



                                       United kingdom



                                       Rest of Europe

                                8.5.3 Asia-Pacific




                                       Australia & New Zealand

                                       South Korea

                                       Rest of Asia-Pacific

                                8.5.4 Middle east & Africa


                                       South Africa

                                       Rest of the Middle East & Africa

                                8.5.5 South America



                                       Rest of South America

9. Competitive Landscape

                9.1 Mergers & Acquisition Analysis

                9.2 Agreements, Collaborations, and Partnerships

                9.3 New Products Launches

10. Key Players

                10.1 Quest Diagnostics

                10.2 Alere Inc

                10.3 GE Healthcare

                10.4 Thermo Fisher Scientific

                10.5 Agilent Technologies

                10.6 Bio-Rad Laboratories

                10.7 Eurofins Scientific

                10.8 Covance

                10.9 Promega Corporation

                10.10 Merck KGaA

                10.11 Others

11. Future of the Market

Purchase Report

Our Clients Include View All

Looking to Customize Report?